Whole genome sequencing of Neisseria meningitidis W isolates from the Czech Republic recovered in 1984-2017
Language English Country United States Media electronic-ecollection
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
Wellcome Trust - United Kingdom
PubMed
30212468
PubMed Central
PMC6136696
DOI
10.1371/journal.pone.0199652
PII: PONE-D-18-16589
Knihovny.cz E-resources
- MeSH
- DNA, Bacterial genetics MeSH
- Phylogeny * MeSH
- Genome, Bacterial * MeSH
- Humans MeSH
- Neisseria meningitidis genetics isolation & purification MeSH
- Sequence Analysis, DNA * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
- Names of Substances
- DNA, Bacterial MeSH
INTRODUCTION: The study presents the analysis of whole genome sequence (WGS) data for Neisseria meningitidis serogroup W isolates recovered in the Czech Republic in 1984-2017 and their comparison with WGS data from other countries. MATERIAL AND METHODS: Thirty-one Czech N. meningitidis W isolates, 22 from invasive meningococcal disease (IMD) and nine from healthy carriers were analysed. The 33-year study period was divided into three periods: 1984-1999, 2000-2009, and 2010-2017. RESULTS: Most study isolates from IMD and healthy carriers were assigned to clonal complex cc22 (n = 10) in all study periods. The second leading clonal complex was cc865 (n = 8) presented by IMD (n = 7) and carriage (n = 1) isolates that emerged in the last study period, 2010-2017. The third clonal complex was cc11 (n = 4) including IMD isolates from the first (1984-1999) and third (2010-2017) study periods. The following clonal complex was cc174 (n = 3) presented by IMD isolates from the first two study periods, i.e. 1984-1999 and 2000-2009. One isolate of each cc41/44 and cc1136 originated from healthy carriers from the second study period, 2000-2009. The comparison of WGS data for N. meningitidis W isolates recovered in the Czech Republic in the study period 1984-2017 and for isolates from other countries recovered in the same period showed that clonal complex cc865, ST-3342 is unique to the Czech Republic since 2010. Moreover, the comparison shows that cc11 in the Czech Republic does not comprise novel hypervirulent lineages reported from both European and non-European countries. All 31 study isolates were assigned to Bexsero® Antigen Sequence Types (BAST), and seven of them were of newly described BASTs. CONCLUSIONS: WGS analysis contributed considerably to a more detailed molecular characterization of N. meningitidis W isolates recovered in the Czech Republic over a 33-year period and allowed for a spatial and temporal comparison of these characteristics between isolates from the Czech Republic and other countries. The most interesting finding of this study is that eight of 31 Czech isolates of N. meningitidis W belong to clonal complex cc865, which is uncommon for serogroup W. In addition, the WGS data precised the base for the update of the recommendation for vaccination in the Czech Republic.
See more in PubMed
Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, Fox A, et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet. 2000; 356(9248):2159 10.1016/S0140-6736(00)03502-9 PubMed DOI
Mayer LW, Reeves MW, Al-Hamdan N, Sacchi CT, Taha MK, Ajello GW, et al. Outbreak of W135 Meningococcal Disease in 2000: Not Emergence of a New W135 Strain but Clonal Expansion within the Electrophoretic Type-37 Complex. J Infect Dis. 2002; 185(11):1596–605. 10.1086/340414 PubMed DOI
Abad R, López EL, Debbag R, Vázquez JA. Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America. Epidemiol Infect. 2014; 142(12):2461–70. 10.1017/S0950268814001149 PubMed DOI PMC
Abad R, Vázquez JA. Early evidence of expanding W ST-11 CC meningococcal incidence in Spain. J Infect. 2016; 73(3):296–7. 10.1016/j.jinf.2016.06.010 PubMed DOI
Aguilera JF, Perrocheau A, Meffre C, Hahné S, W135 Working Group. Outbreak of Serogroup W135 Meningococcal Disease after the Hajj Pilgrimage, Europe, 2000. Emerg Infect Dis. 2002; 8(8):761–7. 10.3201/eid0808.010422 PubMed DOI PMC
Bassi C, Taha MK, Merle C, Hong E, Lévy-Bruhl D, Barret AS, et al. A cluster of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup W among university students, France, February to May 2017. Euro Surveill. 2017; 22(28):pii30574 10.2807/1560-7917.ES.2017.22.28.30574 PubMed DOI PMC
Ladhani SN, Beebeejaun K, Lucidarme J, Campbell H, Gray SJ, Kaczmarski E, et al. Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales. Clin Infect Dis. 2015; 60(4):578–85. 10.1093/cid/ciu881 PubMed DOI
Lucidarme J, Hill DM, Bratcher HB, Gray SJ, du Plessis M, Tsang RS, et al. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage. J Infect. 2015; 71(5):544–52. 10.1016/j.jinf.2015.07.007 PubMed DOI PMC
Lucidarme J, Scott KJ, Ure R, Smith A, Lindsay D, Stenmark B, et al. An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015. Euro Surveill. 2016; 21(45):pii30395 10.2807/1560-7917.ES.2016.21.45.30395 PubMed DOI PMC
Hong E, Barret AS, Terrade A, Denizon M, Antona D, Aouiti-Trabelsi M, et al. Clonal replacement and expansion among invasive meningococcal isolates of serogroup W in France. J Infect. 2018; 76(2):149–58. 10.1016/j.jinf.2017.10.015 PubMed DOI
Rasoanandrasana S, Raberahona M, Milenkov M, Rakotomahefa Narison ML, Ranaivo Rabetokotany F, Rakotovao L, et al. Resurgence of Neisseria meningitidis serogroup W ST-11 (cc11) in Madagascar, 2015–2016. Int J Infect Dis. 2017; 55:1–3. 10.1016/j.ijid.2016.12.001 PubMed DOI
Martin NV, Ong KS, Howden BP, Lahra MM, Lambert SB, Beard FH, et al. Rise in invasive serogroup W meningococcal disease in Australia, 2013–2015. Commun Dis Intell Q Rep. 2016; 40(4):E454–E459. PubMed
Veitch MG, Owen RL. Rise in invasive serogroup W meningococcal disease in Australia 2013–2015. Commun Dis Intell Q Rep. 2016; 40(4):E451–E453. PubMed
Zerbino DR. Using the Velvet de novo assembler for short-read sequencing technologies. Curr Protoc Bioinformatics. 2010; 11(5):1–12. 10.1002/0471250953.bi1105s31 PubMed DOI PMC
Jolley KA, Chan MS, Maiden MC. MlstdbNet–distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics. 2004; 5:86 10.1186/1471-2105-5-86 PubMed DOI PMC
Jolley KA, Maiden MC. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics. 2010; 11:595 10.1186/1471-2105-11-595 PubMed DOI PMC
Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998; 95(6):3140–5. PubMed PMC
Jolley KA, Brehony C, Maiden MC. Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol Rev. 2007; 31(1):89–96. 10.1111/j.1574-6976.2006.00057.x PubMed DOI
Nissen MD, Marshall HS, Richmond PC, Jiang Q, Harris SL, Jones TR, et al. A randomized, controlled, phase ½ trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in a healthy children and adolescents. Pediatr Infect Dis J. 2013; 32(4):364–71. 10.1097/INF.0b013e31827b0d24 PubMed DOI
Vernikos G, Medini D. Bexsero® chronicle. Pathog Glob Health. 2014; 108(7):305–16. 10.1179/2047773214Y.0000000162 PubMed DOI PMC
Bambini S, De Chiara M, Muzzi A, Mora M, Lucidarme J, Brehony C, et al. Neisseria adhesin A variation and revised nomenclature scheme. Clin Vaccine Immunol. 2014; 21(7):966–71. 10.1128/CVI.00825-13 PubMed DOI PMC
Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, Arico B, et al. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med. 2003; 197(6)789–99. 10.1084/jem.20021911 PubMed DOI PMC
Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, Tontini M, et al. Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci U S A. 2010; 107(8):3770–5. 10.1073/pnas.0915162107 PubMed DOI PMC
Brehony C, Rodrigues CMC, Borrow R, Smith A, Cunney R, Moxon ER, et al. Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation. Vaccine. 2016; 34(39):4690–7. 10.1016/j.vaccine.2016.08.015 PubMed DOI PMC
Bratcher HB, Corton C, Jolley KA, Parkhill J, Maiden MC. A gene-by-gene population genomics platform: de novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomes. BMC Genomics. 2014; 15(1):1138 10.1186/1471-15-1138 PubMed DOI PMC
Huson DH. SplitsTree: analyzing and visualizing evolutionary data. Bioinformatics. 1998; 14(1):68–73. 10.1093/bioinformatics/14.1.68 PubMed DOI
He B, Jia Z, Zhou H, Wang Y, Jiang X, Ma H, et al. CC4821 serogroup W meningococcal disease in China. Int J Infect Dis. 2014; 29:113–4. 10.1016/j.ijid.2014.08.022 PubMed DOI
Knol MJ, Hahné SJM, Lucidarme J, Campbell H, de Melker HE, Gray SJ, et al. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. Lancet Public Health. 2017; 2(10):e473–e482. 10.1016/S2468-2667(17)30157-3 PubMed DOI
Eriksson L, Hedberg ST, Jacobsson S, Fredlund H, Mölling P, Stenmark B. Whole genome sequencing of emerging invasive Neisseria meningitidis serogroup W in Sweden. J Clin Microbiol. 2018; 56(4):e01409–17. 10.1128/JCM.01409-17 PubMed DOI PMC
Smith-Palmer A, Oates K, Webster D, Taylor S, Scott KJ, Smith G, et al. Outbreak of Neisseria meningitidis capsular group W among scouts returning from the World Scout Jamboree, Japan, 2015. Euro Surveill. 2016; 21(45):30392 10.2807/1560-7917.ES.2016.21.45.30392 PubMed DOI PMC
Mustapha MM, Marsh JW, Harrison LH. Global epidemiology of capsular group W meningococcal disease (1970–2015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex. Vaccine. 2016; 34(13):1515–23. 10.1016/j.vaccine.2016.02.014 PubMed DOI
Retchless AC, Hu F, Ouédraogo AS, Diarra S, Knipe K, Sheth M, et al. The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012. mSphere. 2016; 1(6):e00201–16. 10.1128/mSphere.00201-16 PubMed DOI PMC
Krizova P, Honskus M, Okonji Z, Musilek M, Kozakova J. Surveillance of invasive meningococcal disease based on whole genome sequencing (WGS), Czech Republic, 2015. Epidemiol Mikrobiol Imunol. 2018; 67(2):64–73. PubMed
Revez J, Espinosa L, Albiger B, Leitmeyer KC, Struelens MJ, ECDC National Microbiology Focal Points and Experts Group. Survey on the Use of Whole-Genome Sequencing for Infectious Diseases Surveillance: Rapid Expansion of European National Capacities, 2015–2016. Front Public Health. 2017; 5:374 10.3389/fpubh.2017.00347 PubMed DOI PMC
Jandova Z, Musilek M, Vackova Z, Kozakova J, Krizova P. Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015. PLoS One. 2016; 11(12):e0167762 10.1371/journal.pone.0167762 PubMed DOI PMC
Campbell H, Saliba V, Borrow R, Ramsay M, Ladhani SN. Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015. Euro Surveill. 2015; 20(28):pii21188 10.2807/1560-7317.ES2015.20.28.21188 PubMed DOI
The National Institute of Public Health, Czech Republic. Recommendations of the Czech Vaccinology Society of the J. E. Purkyně Czech Medical Association for vaccination against invasive meningococcal disease, 15th January 2018. Accessed 5 March 2018. Available: http://www.szu.cz/uploads/IMO/2018_Recommendation_for_vaccination_againts_IMD.pdf
Ladhani SN, Giuliani MM, Biolchi A, Pizza M, Beebeejaun K, Lucidarme J, et al. Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England. Emerg Infect Dis. 2016; 22(2):309–11. 10.3201/eid2202.150369 PubMed DOI PMC
Parikh SR, Campbell H, Beebeejaun K, Ribeiro S, Gray SJ, Borrow R, et al. Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination. Emerg Infect Dis. 2016; 22(8):1505–7. 10.3201/eid2208.160128 PubMed DOI PMC
Genomic surveillance of invasive meningococcal disease in the Czech Republic, 2015-2017